NLS

Veloxis Pharmaceuticals A/S commented on an order issued by the U.S. District Court for the District of Columbia in connection with the action it filed on December 16 against the U.S. Food and Drug Administration (FDA). Veloxis is seeking an order requiring the FDA to grant final approval to Envarsus(® )XR. “We are pleased that […]

For William E. Moerner, research is not something done in isolation; it also is a valuable teaching tool.

Stefan W. Hell, PhD, likes to get down to the fundamentals. As an undergraduate, he disliked hearing professors say, “If you do the maths, you’ll know why this is so.” He was convinced everything could be reduced to the simplest principles and spent hours, as he put it in his autobiography, “trying to distill concepts and phenomena down to their essence.”

Despite earning multiple degrees in physics and all his years doing research, Nobel Prize winner Dr. Eric Betzig sees himself foremost as a tool builder.

In a study published this month, scientists at the Karolinska Institute in Stockholm found that exercise can change the shape and function of genes. Through a process called methylation, clusters of atoms, called methyl groups, attach to the outside of a gene and make the gene more or less able to receive and respond to biochemical […]

Biopharmaceutical firm Lundbeck A/S announced that it would discontinue future research into its experimental stroke drug compound desmoteplase, despite two previous studies showing positive patient effects and fast-track designation from the U.S. Food and Drug Administration (FDA) for the treatment of acute ischemic stroke. Lundbeck would take a write down of $51.26 million for the […]